Page results
-
Having proton beam therapy: information for children aged 9-12 patient information
-
Having proton beam therapy: information for children aged 5-8 patient information page.
-
University College London Hospitals (UCLH) is now administering new COVID-19 treatments for patients at highest risk in the community.
-
UCLH NHS Foundation Trust has once again formed a partnership with the Business Design Centre in Islington to reopen a large-scale COVID-19 vaccination centre on site from Saturday 18 December.
-
The National Paediatric Diabetes Audit (NPDA) is asking all children and young people (8-19 years) and parents/carers (of children under 8 years old) who have received diabetes care in the past 6 months, to fill in the survey.
-
A new CAR T-cell therapy developed by scientists at UCL has fewer ‘toxic’ side-effects and is more durable, targeting and killing cancer cells for longer, concludes a Phase 1 clinical trial of patients at UCLH.
-
When Sam Ahern was born 24 years ago, she was the smallest baby our neonatal unit had ever looked after. Now an accomplished musician and fine art student, she has gone back to meet the team that helped her win her fight for life.
-
You now need a registered site administrator to access EpicCare Link UCLH for your practice or service. If your site doesn’t have a registered administrator, you may lose access to EpicCare Link UCLH.
-
UCLH has continued to achieve excellent results in the National Inpatient Survey, with patients rating their overall care as 8.7 out of 10 – the top score amongst our London peers.
-
UCH Chemotherapy Daycare and the Macmillan Support and Information Service are shortlisted for a Patient Experience Network National Award for the use of data from the Cancer Patient Experience Survey to improve patient experience.
File results
-
FOI/2024/0333 - Elective treatment wait over 65 weeks
-
FOI/2024/0467 - Drug Patient Level Contract Monitoring (DrPLCM) and SACT Cancer reports
-
FOI/2024/0464 - Theatre sessions/ productivity
-
FOI/2024/0329 - Metastatic renal cell carcinoma patients/ classification
-
FOI/2024/0327 - Treatment of non-UK nationals
-
FOI/2024/0326 - Treatment of Haemophilia B and Von Willebrand disease
-
FOI/2024/0320 - Treatment for rare diseases; fabry, gaucher and pompe diseases
-
FOI/2024/0291 - Private patient income 2020-2023
-
FOI/2024/0297 - Policy for parasitic infestation assessment and treatment of patients
-
FOI/2024/0295 - MRI scanners at Trust 2019/2020 and 2022/24